צפואבניר 500 מ"ג - Cefuavenir 500 mg
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ××× ×× ×× × ×ספ×× | |
|---|---|
| ×§×××¦× ×¤×¨××§×××××ת (ATC4) | J01DC Second-generation cephalosporins |
| ×ר××× ×¤×¢×× (ATC5) | Â
|
| צ×רת ××ª× | פ××× - PER OS |
| צ×רת ××× ×× | ×××××, TABLETS ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× |
| ×ת×××× | CefuAvenir is indicated for the treatment of the infections listed below in adults and children from the age of 3 :months .⢠Acute streptococcal tonsillitis and pharyngitis.⢠Acute bacterial sinusitis.⢠Acute otitis media.⢠Acute exacerbations of chronic bronchitis.⢠Cystitis.⢠Pyelonephritis.⢠Uncomplicated skin and soft tissue infections. â¢Treatment of early Lyme disease.Consideration should be given to official guidance on the appropriate use of antibacterial agents. |
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
  |
| ×¢××× ×צר×× |  |
|---|
| ער××× ×××××§×רפ××× | ער××× ×§×©×ר×× ×××××§×רפ××× |
|---|---|
| צפ×××× ×ר 500 ×"× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | NECTAR LIFE SCIENCE LTD., INDIA |
| ×©× ××¢× ×ר×ש×× | BIOAVENIR LTD, ISRAEL |
| ר×ש××× | ת×ר×× ××ש×: 5/2019. ר×ש××× ×ת×ר××: |
| ת×ר×× ×¢×××× ××ר×× | 14/07/2024 |
השינוי האחרון נעשה בֹ־14 ביולי 2024 ב־02:49